Sat.Apr 20, 2024 - Fri.Apr 26, 2024

Remove drug-development-healthcare-technology
article thumbnail

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By

article thumbnail

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

Predictive modeling: Machine learning algorithms can be used to develop models that can predict a patient's risk of developing a particular disease. Personalised medicine: ML algorithms can be used to analyze a patient's individual medical data to develop personalised treatment plans. Visit www.nelsonadvisors.co.uk

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How AI is Shaping Drug Discovery at AION Labs

Healthcare IT Today

In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development. The marriage of AI and pharmaceuticals holds immense promise, particularly in the realm of drug discovery.

article thumbnail

Average Multiples in HealthTech M&A deals: April 2024

Lloyd Price

Drug discovery companies: 7.0x Healthcare IT companies: 3.5x Drug discovery companies: 7.0x Healthcare IT companies: 3.5x Strategic deals: M&A activity is likely to continue, but with a focus on strategic deals that bring together complementary technologies or expertise. Wellness companies: 4.0x

article thumbnail

Zephyr AI Raises $111 Million in Series A Financing

Healthcare IT Today

The company is developing improved data federation tools along with various machine learning algorithms in the areas of oncology and cardiometabolic disease. Second, leveraging recent breakthroughs in representation learning, the technology elucidates the biological context underlying its predictions.